they werent relying solely on multivitamins
Avoid Harsh Actives: A suitable option for individuals who cannot use exfoliating acids or retinoids
Survodutide : An investigational dual GLP-1/glucagon receptor agonist, early trials have shown meaningful weight loss and metabolic improvements
What GHK-Cu does not do, based on the mechanistic literature, is directly block the 5-alpha reductase enzyme the way finasteride does
Lancet 359:20532058 Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E, Committees T, Investigators (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia